A new study suggests that the blood glucose self-monitoring is not in any way beneficial to non-insulin-dependent type 2 diabetes patients. The Institute for Quality and Efficiency in Health Care (IQWiG) published the report on December 14, 2009.
IQWiG looked for comparative trials with and without self-monitoring. One group was with allowed self-monitoring and the other was kept without it.
IQWiG and its external experts conducted six trials. All explored the advantage of blood glucose self-monitoring. The duration of trials ranged from six to 12 months.
The few data that were realised did not suggest any benefit of self-monitoring.
However, the research, which also questioned the advantage of blood test compared to the urine test or vice versa, missed out on trials of longer duration that help to assess the long-term effects of glucose self-monitoring.
Comments